Healius Share Price and Company Fundamentals
Last traded: Today at 2:19 AM
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Key Metrics
PE ratio
-
PB ratio
1.14
Dividend yield
-
Beta
0.35
Market cap
$671.67M
Enterprise value
$1.53B
Company profile
| Industry / Sector | Diagnostics & Research / Healthcare |
|---|---|
| Full time employees | 3699 |
| Website | https://www.healius.com.au |
| Mailing address | 161 Castlereagh Street Level 22 Sydney NSW 2000 Australia |
| Phone / Fax | 61 2 9432 9400 / 61 2 9432 9447 |
Dividends
More: Healius Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Healius paid $- dividend and the ex-dividend date was 09 May 2025.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HLS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Healius.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Paul D. Anderson B.Com., C.A. | MD, CEO & Director | ||
| Mr. Andrew Thomson | CFO & Company Secretary | ||
| Mr. Puneet Nagi M.B.A. | Chief Operating Officer | ||
| Mr. Prasad Arav | Group Executive of Digital & Technology and Strategy | ||
| Sharon Ng | Head of FP&A and Investor Relations | ||
| Ms. Kylie Brown | Group General Counsel, Company Secretary & Chief Risk Officer | ||
| Ms. Paula Bayliss | Group Executive of People & Culture | ||
| Mr. John McKechnie | Advisor | ||
| Dr. Phil Lucas | Chief Executive of Lumus Imaging | ||
| Ian Mcphan | Chief Operating Officer of Healius Pathology |
Profitability and management effectiveness
Profit margin
-11.25%
Operating margin
0.01%
Return on assets
0.01%
Return on equity
-69.14%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Healius is 671.67M and its enterprise value is 1.53B. The enterprise value to revenue ratio of HLS is 1.14. The enterprise value to EBITDA ratio of HLS is 49.15.
The HLS's stocks Beta value is 0.35 making it 65% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Healius (HLS)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Healius (ASX:HLS) Frequently Asked Questions
1. What is Healius's Stock Symbol?
Healius trades on ASX under the ticker symbol "HLS".
2. What is Healius's stock price today?
One share of HLS stock can currently be purchased for approximately $0.925.
3. How can I contact Healius?
Healius's mailing address is 161 Castlereagh Street Level 22 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9432 9400.
4. What is Healius's official website?
The official website of Healius is https://www.healius.com.au.